Correlation Engine 2.0
Clear Search sequence regions


  • angiogenesis (1)
  • drug target (1)
  • gene (1)
  • ligand (1)
  • methyl (1)
  • mice (4)
  • mice knockout (1)
  • microglia (2)
  • NADPH (3)
  • NOX1 (3)
  • oxygen (2)
  • protein target (1)
  • purines (2)
  • receptors gaba (2)
  • retina (1)
  • signal (1)
  • species (2)
  • tamoxifen (1)
  • therapies (1)
  • TSPO (7)
  • xbd173 (2)
  • Sizes of these terms reflect their relevance to your search.

    Aberrant immune responses including reactive phagocytes are implicated in the etiology of age-related macular degeneration (AMD), a major cause of blindness in the elderly. The translocator protein (18 kDa) (TSPO) is described as a biomarker for reactive gliosis, but its biological functions in retinal diseases remain elusive. Here, we report that tamoxifen-induced conditional deletion of TSPO in resident microglia using Cx3cr1CreERT2:TSPOfl/fl mice or targeting the protein with the synthetic ligand XBD173 prevents reactivity of phagocytes in the laser-induced mouse model of neovascular AMD. Concomitantly, the subsequent neoangiogenesis and vascular leakage are prevented by TSPO knockout or XBD173 treatment. Using different NADPH oxidase-deficient mice, we show that TSPO is a key regulator of NOX1-dependent neurotoxic ROS production in the retina. These data define a distinct role for TSPO in retinal phagocyte reactivity and highlight the protein as a drug target for immunomodulatory and antioxidant therapies for AMD.

    Citation

    Anne Wolf, Marc Herb, Michael Schramm, Thomas Langmann. The TSPO-NOX1 axis controls phagocyte-triggered pathological angiogenesis in the eye. Nature communications. 2020 Jun 01;11(1):2709

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32483169

    View Full Text